Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Abiraterone Acetate Combined With Dutasteride With Correlative Assessment of Tumor Androgen Levels and Androgen Receptor Sequence and Signaling at Baseline and at Progression

NCT01393730 is registered in ClinicalTrials.gov with Mary-Ellen Taplin, MD as lead sponsor.

NCT NCT01393730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01393730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Abiraterone Acetate Combined With Dutasteride With Correlative Assessment of Tumor Androgen Levels and Androgen Receptor Sequence and Signaling at Baseline and at Progression
Lead sponsor
Mary-Ellen Taplin, MD
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2011
Completion date
March 15, 2017
Enrollment
40 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer